76 results
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
2 May 24
Inspira™ Announces Start of Production of the INSPIRA™ ART100
9:47am
Administration (FDA) regulatory clearance.
About Inspira Technologies OXY B.H.N. Ltd.
Inspira™ Technologies is an innovative medical technology company
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
25 Apr 24
Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
9:00am
, design or performance of a wide range of products and services.
About Inspira Technologies OXY B.H.N. Ltd.
Inspira™ Technologies is an innovative
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
17 Apr 24
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
6:43am
in developing and implementing innovative treatments while maintaining the highest standards of quality medical and care. Beilinson Hospital … in transplant procedures in the country.
About Inspira Technologies OXY B.H.N. Ltd.
Inspira™ Technologies is an innovative medical technology company
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
10 Apr 24
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
8:50am
.
Inspira™ Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
3 Apr 24
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
8:56am
the landscape of acute neonatal care.”
Inspira Technologies OXY B.H.N. Ltd.
Inspira™ Technologies is an innovative medical technology company
6-K
EX-99.1
z82ev7
1 Apr 24
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
8:46am
6-K
EX-99.1
616rfcps6bts3z8eisqk
25 Mar 24
Inspira™ Technologies Reports Full Year 2023 Financial Results
9:27am
6-K
EX-99.1
svcl lnh18dik3299jk
18 Mar 24
Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets
7:08am
6-K
EX-99.1
97vblzyl9p1eww zp6
12 Mar 24
Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
4:01pm
6-K
EX-99.1
f01zk l22vc
4 Mar 24
Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days
9:25am
6-K
EX-99.1
zbiohmu
27 Feb 24
Report of Foreign Private Issuer
7:15am
6-K
EX-99.2
zr31o
27 Feb 24
Report of Foreign Private Issuer
7:15am
6-K
EX-99.1
cfr9p6k7nclochbfz
22 Feb 24
Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies
9:18am
6-K
EX-99.1
qcodpum4 6aeu9w1xcj
14 Feb 24
Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
9:18am
6-K
EX-99.1
hdxbus2m7b4cya6
8 Feb 24
Report of Foreign Private Issuer
9:15am
6-K
EX-99.1
b361e
30 Jan 24
Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices
8:40am
6-K
EX-99.1
vund7puozfiuy6f6ln
9 Jan 24
Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity
9:00am
6-K
EX-99.1
181juxk6ffg8
2 Jan 24
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
9:05am
6-K
EX-99.1
9r5d38 fz7xtn29o3
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm